Loading
Showed that MGUS precedes essentially all myeloma and leads MRD-driven trials aiming for cure without transplant.
Ola Landgren led the prospective studies showing that monoclonal gammopathy of undetermined significance precedes virtually every case of multiple myeloma, defining the disease's precursor states, and now leads MRD-driven trials such as MANHATTAN and the daratumumab-KRd studies that achieve MRD negativity in most patients without transplant. He co-leads the international effort that made MRD an FDA-accepted endpoint.
Shares CD38, MRD / molecular residual disease testing, Multiple myeloma and the tag myeloma.
Shares CD38, Multiple myeloma and the tag myeloma.
Shares MRD / molecular residual disease testing, Multiple myeloma and the tag myeloma.
Shares CD38, Multiple myeloma and the tag myeloma.
Shares CD38, Multiple myeloma and the tag myeloma.
Shares CD38, Multiple myeloma and the tag myeloma.
Shares CD38, Multiple myeloma and the tag myeloma.
Shares MRD / molecular residual disease testing, Multiple myeloma and the tag myeloma.